IGF2BP2 and obesity due to melanocortin 4 receptor deficiency: Dysregulation of IMP2 is linked to several metabolic dysfunctions, including wound healing, type 2 diabetes (T2D), obesity, fatty liver disease, and cancer, highlighting its potential as a therapeutic target [13].